Alcon (ALC) Other Non-Current Liabilities (2009 - 2026)
Alcon (ALC) posted Other Non-Current Liabilities of $846.0 million for Q2 2026, down 9.32% on a QoQ basis from $933.0 million in Q1 2026, and down 2.98% year-over-year from $872.0 million in Q2 2025.
Analysis
Alcon (ALC) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Alcon has reported Other Non-Current Liabilities for 11 years, with the latest figure at $846.0 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 2.98% year-over-year to $846.0 million in Q2 2026; TTM through Jun 2026 was $846.0 million, a 2.98% decrease from a year earlier, with the FY2025 full-year figure at $939.0 million, up 13.82% from the prior year.
- Other Non-Current Liabilities was $846.0 million for Q2 2026 at Alcon, down from $933.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $944.0 million in Q3 2025, with the low at $707.0 million in Q3 2022.
- Average Other Non-Current Liabilities over 5 years is $819.4 million, with a median of $816.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities decreased 27.04% in 2022, then rose 18.15% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $786.0 million in 2022, then retreated by 0.25% to $784.0 million in 2023, then grew by 5.23% to $825.0 million in 2024, then gained by 13.82% to $939.0 million in 2025, then retreated by 9.9% to $846.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $846.0 million (Q2 2026), $933.0 million (Q1 2026), and $939.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 846.00 Mn |
| Mar 31, 2026 | 933.00 Mn |
| Dec 31, 2025 | 939.00 Mn |
| Sep 30, 2025 | 944.00 Mn |
| Jun 30, 2025 | 872.00 Mn |
| Dec 31, 2024 | 825.00 Mn |
| Sep 30, 2024 | 799.00 Mn |
| Jun 30, 2024 | 763.00 Mn |
| Mar 31, 2024 | 768.00 Mn |
| Dec 31, 2023 | 784.00 Mn |
| Sep 30, 2023 | 727.00 Mn |
| Jun 30, 2023 | 832.00 Mn |
| Mar 31, 2023 | 816.00 Mn |
| Dec 31, 2022 | 786.00 Mn |
| Sep 30, 2022 | 707.00 Mn |
| Jun 30, 2022 | 743.00 Mn |
| Mar 31, 2022 | 845.00 Mn |
| Dec 31, 2021 | 940.00 Mn |
| Sep 30, 2021 | 969.00 Mn |
| Jun 30, 2021 | 1.02 Bn |